| AU: Analogue of MDMA
UK: Class B
US: Analogue to a Schedule I/II drug (MDMA)|
6-EAPB (1-(benzofuran-6-yl)-N-ethylpropan-2-amine) is a psychedelic and entactogenic drug of the benzofuran class; it is structurally related to 6-APB and MDMA.
As an N-ethyl derivative of 6-APB, 6-EAPB fell outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013. The ACMD has advised that 6-EAPB (and other benzofurans) are moved to Class B, this came into action on 10 June 2014.